Cargando…

The Combination of High Levels of Adiponectin and Insulin Resistance Are Affected by Aging in Non-Obese Old Peoples

BACKGROUND: Adipokine dysregulation is a key feature of insulin resistance and a metabolic syndrome associated with obesity. Low adiponectin levels are associated with higher risks of cardiovascular diseases (CVD). However, high adiponectin levels have also been associated with increased all-cause a...

Descripción completa

Detalles Bibliográficos
Autores principales: Muratsu, Jun, Kamide, Kei, Fujimoto, Takashi, Takeya, Yasushi, Sugimoto, Ken, Taniyama, Yoshiaki, Morishima, Atsuyuki, Sakaguchi, Katsuhiko, Matsuzawa, Yuji, Rakugi, Hiromi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777034/
https://www.ncbi.nlm.nih.gov/pubmed/35069451
http://dx.doi.org/10.3389/fendo.2021.805244
_version_ 1784636971770970112
author Muratsu, Jun
Kamide, Kei
Fujimoto, Takashi
Takeya, Yasushi
Sugimoto, Ken
Taniyama, Yoshiaki
Morishima, Atsuyuki
Sakaguchi, Katsuhiko
Matsuzawa, Yuji
Rakugi, Hiromi
author_facet Muratsu, Jun
Kamide, Kei
Fujimoto, Takashi
Takeya, Yasushi
Sugimoto, Ken
Taniyama, Yoshiaki
Morishima, Atsuyuki
Sakaguchi, Katsuhiko
Matsuzawa, Yuji
Rakugi, Hiromi
author_sort Muratsu, Jun
collection PubMed
description BACKGROUND: Adipokine dysregulation is a key feature of insulin resistance and a metabolic syndrome associated with obesity. Low adiponectin levels are associated with higher risks of cardiovascular diseases (CVD). However, high adiponectin levels have also been associated with increased all-cause and cardiovascular mortality in the elderly. This adiponectin paradox has yet to be clarified, which has hindered our understanding of the biological role of adiponectin. Adipokine dysregulation and insulin resistance are also associated with energy-deprivation conditions, such as frailty in old age. The objective of this study was to investigate the association between plasma adiponectin and insulin resistance using the homeostasis model assessment for insulin resistance (HOMA-IR) classified by age. In particular, we sought to determine the factors of the subjects associated with both high adiponectin levels and HOMA-IR (H-adiponectin/H-HOMA) and high adiponectin levels and low HOMA-IR (H-adiponectin/L-HOMA). METHODS: The eligible subjects in this cross-sectional study were 33,216 individuals who had undergone health checkups at the Physical Checkup Center of Sumitomo Hospital between April 2008 and December 2018. After excluding 26,371 individuals who were under 60 years old, 529 who had been taking medications for diabetes mellitus, and 690 with missing data, the present study included 5,673 (3,467 males, 2,206 females) subjects with no missing data. The relationship between serum adiponectin levels and HOMA-IR was assessed using logistic regression models adjusted by clinically relevant factors. RESULTS: In the multivariable logistic regression analysis, age and low BMI were shown to positively correlate with the characteristics of H-adiponectin/H-HOMA. In females, systolic blood pressure was also shown to be an associated factor. CONCLUSION: In conclusion, this study showed that aging or a low BMI may contribute to high adiponectin levels and insulin resistance.
format Online
Article
Text
id pubmed-8777034
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87770342022-01-22 The Combination of High Levels of Adiponectin and Insulin Resistance Are Affected by Aging in Non-Obese Old Peoples Muratsu, Jun Kamide, Kei Fujimoto, Takashi Takeya, Yasushi Sugimoto, Ken Taniyama, Yoshiaki Morishima, Atsuyuki Sakaguchi, Katsuhiko Matsuzawa, Yuji Rakugi, Hiromi Front Endocrinol (Lausanne) Endocrinology BACKGROUND: Adipokine dysregulation is a key feature of insulin resistance and a metabolic syndrome associated with obesity. Low adiponectin levels are associated with higher risks of cardiovascular diseases (CVD). However, high adiponectin levels have also been associated with increased all-cause and cardiovascular mortality in the elderly. This adiponectin paradox has yet to be clarified, which has hindered our understanding of the biological role of adiponectin. Adipokine dysregulation and insulin resistance are also associated with energy-deprivation conditions, such as frailty in old age. The objective of this study was to investigate the association between plasma adiponectin and insulin resistance using the homeostasis model assessment for insulin resistance (HOMA-IR) classified by age. In particular, we sought to determine the factors of the subjects associated with both high adiponectin levels and HOMA-IR (H-adiponectin/H-HOMA) and high adiponectin levels and low HOMA-IR (H-adiponectin/L-HOMA). METHODS: The eligible subjects in this cross-sectional study were 33,216 individuals who had undergone health checkups at the Physical Checkup Center of Sumitomo Hospital between April 2008 and December 2018. After excluding 26,371 individuals who were under 60 years old, 529 who had been taking medications for diabetes mellitus, and 690 with missing data, the present study included 5,673 (3,467 males, 2,206 females) subjects with no missing data. The relationship between serum adiponectin levels and HOMA-IR was assessed using logistic regression models adjusted by clinically relevant factors. RESULTS: In the multivariable logistic regression analysis, age and low BMI were shown to positively correlate with the characteristics of H-adiponectin/H-HOMA. In females, systolic blood pressure was also shown to be an associated factor. CONCLUSION: In conclusion, this study showed that aging or a low BMI may contribute to high adiponectin levels and insulin resistance. Frontiers Media S.A. 2022-01-07 /pmc/articles/PMC8777034/ /pubmed/35069451 http://dx.doi.org/10.3389/fendo.2021.805244 Text en Copyright © 2022 Muratsu, Kamide, Fujimoto, Takeya, Sugimoto, Taniyama, Morishima, Sakaguchi, Matsuzawa and Rakugi https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Muratsu, Jun
Kamide, Kei
Fujimoto, Takashi
Takeya, Yasushi
Sugimoto, Ken
Taniyama, Yoshiaki
Morishima, Atsuyuki
Sakaguchi, Katsuhiko
Matsuzawa, Yuji
Rakugi, Hiromi
The Combination of High Levels of Adiponectin and Insulin Resistance Are Affected by Aging in Non-Obese Old Peoples
title The Combination of High Levels of Adiponectin and Insulin Resistance Are Affected by Aging in Non-Obese Old Peoples
title_full The Combination of High Levels of Adiponectin and Insulin Resistance Are Affected by Aging in Non-Obese Old Peoples
title_fullStr The Combination of High Levels of Adiponectin and Insulin Resistance Are Affected by Aging in Non-Obese Old Peoples
title_full_unstemmed The Combination of High Levels of Adiponectin and Insulin Resistance Are Affected by Aging in Non-Obese Old Peoples
title_short The Combination of High Levels of Adiponectin and Insulin Resistance Are Affected by Aging in Non-Obese Old Peoples
title_sort combination of high levels of adiponectin and insulin resistance are affected by aging in non-obese old peoples
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777034/
https://www.ncbi.nlm.nih.gov/pubmed/35069451
http://dx.doi.org/10.3389/fendo.2021.805244
work_keys_str_mv AT muratsujun thecombinationofhighlevelsofadiponectinandinsulinresistanceareaffectedbyaginginnonobeseoldpeoples
AT kamidekei thecombinationofhighlevelsofadiponectinandinsulinresistanceareaffectedbyaginginnonobeseoldpeoples
AT fujimototakashi thecombinationofhighlevelsofadiponectinandinsulinresistanceareaffectedbyaginginnonobeseoldpeoples
AT takeyayasushi thecombinationofhighlevelsofadiponectinandinsulinresistanceareaffectedbyaginginnonobeseoldpeoples
AT sugimotoken thecombinationofhighlevelsofadiponectinandinsulinresistanceareaffectedbyaginginnonobeseoldpeoples
AT taniyamayoshiaki thecombinationofhighlevelsofadiponectinandinsulinresistanceareaffectedbyaginginnonobeseoldpeoples
AT morishimaatsuyuki thecombinationofhighlevelsofadiponectinandinsulinresistanceareaffectedbyaginginnonobeseoldpeoples
AT sakaguchikatsuhiko thecombinationofhighlevelsofadiponectinandinsulinresistanceareaffectedbyaginginnonobeseoldpeoples
AT matsuzawayuji thecombinationofhighlevelsofadiponectinandinsulinresistanceareaffectedbyaginginnonobeseoldpeoples
AT rakugihiromi thecombinationofhighlevelsofadiponectinandinsulinresistanceareaffectedbyaginginnonobeseoldpeoples
AT muratsujun combinationofhighlevelsofadiponectinandinsulinresistanceareaffectedbyaginginnonobeseoldpeoples
AT kamidekei combinationofhighlevelsofadiponectinandinsulinresistanceareaffectedbyaginginnonobeseoldpeoples
AT fujimototakashi combinationofhighlevelsofadiponectinandinsulinresistanceareaffectedbyaginginnonobeseoldpeoples
AT takeyayasushi combinationofhighlevelsofadiponectinandinsulinresistanceareaffectedbyaginginnonobeseoldpeoples
AT sugimotoken combinationofhighlevelsofadiponectinandinsulinresistanceareaffectedbyaginginnonobeseoldpeoples
AT taniyamayoshiaki combinationofhighlevelsofadiponectinandinsulinresistanceareaffectedbyaginginnonobeseoldpeoples
AT morishimaatsuyuki combinationofhighlevelsofadiponectinandinsulinresistanceareaffectedbyaginginnonobeseoldpeoples
AT sakaguchikatsuhiko combinationofhighlevelsofadiponectinandinsulinresistanceareaffectedbyaginginnonobeseoldpeoples
AT matsuzawayuji combinationofhighlevelsofadiponectinandinsulinresistanceareaffectedbyaginginnonobeseoldpeoples
AT rakugihiromi combinationofhighlevelsofadiponectinandinsulinresistanceareaffectedbyaginginnonobeseoldpeoples